BioStem Technologies, Inc. (BSEM) vs eXoZymes, Inc. (EXOZ)
A side-by-side comparison of BioStem Technologies, Inc. and eXoZymes, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BSEM
BioStem Technologies, Inc.
$2.62HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
EXOZ
eXoZymes, Inc.
$5.60HealthcareDelayed quote: Oct 6, 2026, 11:28 AM EDT
Total return — BSEM vs EXOZ
growth of $100 · dividends reinvested · last 2yBSEM -88.2% (-65.6%/yr)EXOZ -36.2% (-20.1%/yr)EXOZ compounded faster over this window
Log scale — wide-divergence pair
BSEM EXOZ
BSEM vs EXOZ: by the numbers
- •EXOZ is the larger company ($52M vs $44M market cap).
- •Both run net losses; EXOZ's is the smaller (0.00% vs -13.86% net margin).
Metrics side by side
Valuation
| Metric | BSEM | EXOZ |
|---|---|---|
| P/B ratio | 1.61 | 14.22 |
Profitability
| Metric | BSEM | EXOZ |
|---|---|---|
| Gross margin | 93.13% | 0.00% |
| Operating margin | -1.45% | 0.00% |
| Net margin | -13.86% | 0.00% |
| ROE | -102.45% | -278.89% |
| ROIC | -80.92% | -157.40% |
Growth (annualized)
| Metric | BSEM | EXOZ |
|---|---|---|
| Total return CAGR (5Y) | 15.72% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.